Pacira Pharmaceuticals (PCRX)
NASDAQ:PCRX

Pacira Pharmaceuticals (PCRX) Technical Analysis

329 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Pacira Pharmaceuticals’s (PCRX) Moving Averages Convergence Divergence (MACD) indicator is -2.15, suggesting Pacira Pharmaceuticals is a Buy.
Pacira Pharmaceuticals’s (PCRX) 20-Day exponential moving average is 23.01, while Pacira Pharmaceuticals’s (PCRX) share price is $19.37, making it a Sell.
Pacira Pharmaceuticals’s (PCRX) 50-Day exponential moving average is 25.66, while Pacira Pharmaceuticals’s (PCRX) share price is $19.37, making it a Sell.

Pacira Pharmaceuticals (PCRX) Pivot Points

Jul 25, 2024, 10:41 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
17.89
18.95
19.58
20.64
21.27
22.33
22.96
Fibonacci
18.95
19.59
19.99
20.64
21.28
21.68
22.33
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pacira Pharmaceuticals (PCRX) Moving Averages

Jul 25, 2024, 10:41 PM
Period
Simple
Exponential
MA5
20.65Sell
20.42Sell
MA10
20.87Sell
21.29Sell
MA20
23.64Sell
23.01Sell
MA50
27.27Sell
25.66Sell
MA100
27.78Sell
27.37Sell
MA200
28.91Sell
29.32Sell
Pacira Pharmaceuticals’s (PCRX) 10-Day exponential moving average is 21.29, while Pacira Pharmaceuticals’s (PCRX) share price is $19.37, making it a Sell.
Pacira Pharmaceuticals’s (PCRX) 100-Day exponential moving average is 27.37, while Pacira Pharmaceuticals’s (PCRX) share price is $19.37, making it a Sell.
Pacira Pharmaceuticals’s (PCRX) stock price is $19.37 and Pacira Pharmaceuticals’s (PCRX) 50-day simple moving average is 27.27, creating a Sell signal.
Pacira Pharmaceuticals’s (PCRX) stock price is $19.37 and Pacira Pharmaceuticals’s (PCRX) 100-day simple moving average is 27.78, creating a Sell signal.
Pacira Pharmaceuticals’s (PCRX) stock price is $19.37 and Pacira Pharmaceuticals’s (PCRX) 200-day simple moving average is 28.91, creating a Sell signal.

Pacira Pharmaceuticals (PCRX) Technical Indicators

Jul 25, 2024, 10:41 PM
Name
Value
Implied Action
RSI (14)
25.22
Buy
STOCH (9,6)
17.11
Buy
STOCHRSI (14)
4.17
Buy
MACD (12,26)
-2.15
Buy
ADX (14)
32.97
Neutral
Williams %R
-99.70
Buy
CCI (14)
-82.42
Neutral
ATR (14)
1.33
-
Ultimate Oscillator
35.66
Neutral
ROC
-32.30
Sell
Pacira Pharmaceuticals’s (PCRX) Relative Strength Index (RSI) is 25.22, creating a Buy signal.
Pacira Pharmaceuticals’s (PCRX) Trend Strength Indicator (ADX) is 32.97, creating a Neutral signal.
Pacira Pharmaceuticals’s (PCRX) Commodity Channel Index (CCI) is -82.42, creating a Neutral signal.
Pacira Pharmaceuticals’s (PCRX) Price Rate of Change (ROC) is -32.30, creating a Sell signal.

FAQ

Is PCRX a Buy, Hold, or Sell?
Based on PCRX’s technical indicators, PCRX is a Sell.
    What is PCRX’s RSI (14)?
    PCRX’s RSI (14) is 25.22, which suggests PCRX is a Buy.
      What is PCRX’s MACD?
      PCRX’s MACD is -2.15, which suggests PCRX is a Buy.
        What is PCRX’s 5-day moving average?
        PCRX’s 5-day moving average is 20.65, which suggests PCRX is a Sell.
          What is PCRX’s 20-day moving average?
          PCRX 20-day moving average is 23.64, which suggests PCRX is a Sell.
            What is PCRX’s 50-day moving average?
            PCRX’s 50-day moving average is 27.27, which suggests PCRX is a Sell.
              What is PCRX’s 200-day moving average?
              PCRX’s 200-day moving average is 28.91, which suggests PCRX is a Sell.
                What is PCRX’s Williams % R (14)?
                PCRX’s Williams % R (14) is -99.70, which suggests PCRX is a Buy.
                  What is PCRX’s CCI (14)?
                  PCRX’s CCI (14) is -82.42, which suggests PCRX is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis